Management of macular epiretinal membrane by vitrectomy and intravitreal triamcinolone

A patient underwent successful vitrectomy for macular epiretinal membrane with anatomical and functional improvement. 10 weeks later, there was a recurrence of macular edema with corresponding visual decline. An intravitreal injection of triamcinolone acetonide not only restored the macular anatomy...

Descripción completa

Detalles Bibliográficos
Autor principal: Shukla, Dhananjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064239/
https://www.ncbi.nlm.nih.gov/pubmed/23571236
http://dx.doi.org/10.4103/0301-4738.99850
_version_ 1782321924992401408
author Shukla, Dhananjay
author_facet Shukla, Dhananjay
author_sort Shukla, Dhananjay
collection PubMed
description A patient underwent successful vitrectomy for macular epiretinal membrane with anatomical and functional improvement. 10 weeks later, there was a recurrence of macular edema with corresponding visual decline. An intravitreal injection of triamcinolone acetonide not only restored the macular anatomy but also improved the visual outcome beyond that achieved after surgery.
format Online
Article
Text
id pubmed-4064239
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-40642392014-06-25 Management of macular epiretinal membrane by vitrectomy and intravitreal triamcinolone Shukla, Dhananjay Indian J Ophthalmol Brief Communications A patient underwent successful vitrectomy for macular epiretinal membrane with anatomical and functional improvement. 10 weeks later, there was a recurrence of macular edema with corresponding visual decline. An intravitreal injection of triamcinolone acetonide not only restored the macular anatomy but also improved the visual outcome beyond that achieved after surgery. Medknow Publications & Media Pvt Ltd 2014-04 /pmc/articles/PMC4064239/ /pubmed/23571236 http://dx.doi.org/10.4103/0301-4738.99850 Text en Copyright: © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communications
Shukla, Dhananjay
Management of macular epiretinal membrane by vitrectomy and intravitreal triamcinolone
title Management of macular epiretinal membrane by vitrectomy and intravitreal triamcinolone
title_full Management of macular epiretinal membrane by vitrectomy and intravitreal triamcinolone
title_fullStr Management of macular epiretinal membrane by vitrectomy and intravitreal triamcinolone
title_full_unstemmed Management of macular epiretinal membrane by vitrectomy and intravitreal triamcinolone
title_short Management of macular epiretinal membrane by vitrectomy and intravitreal triamcinolone
title_sort management of macular epiretinal membrane by vitrectomy and intravitreal triamcinolone
topic Brief Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064239/
https://www.ncbi.nlm.nih.gov/pubmed/23571236
http://dx.doi.org/10.4103/0301-4738.99850
work_keys_str_mv AT shukladhananjay managementofmacularepiretinalmembranebyvitrectomyandintravitrealtriamcinolone

Ejemplares similares